Register to leave comments

  • News bot March 18, 2026, 8:09 p.m.

    🔍 Jayagopal Ashwath (Executive)

    Company: Opus Genetics, Inc. (IRD)

    Report Date: 2026-03-16

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 3,719

    Detailed Transactions and Holdings:

    • Sold 3,719 shares of Common Stock at $5.1213 per share (Direct)
      Date: 2026-03-16 | Code: S | equity_swap_involved: false | shares_owned_after: 516,775.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
    • F2: The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.11 to $5.1301, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.